58 Stocks Moving In Thursday’s Mid-Day Session
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 102.6% to $0.1580 after declining 9% on Wednesday. Allena Pharmaceuticals recently reported a $2.8 million registered direct offering.
Why Are Cullinan Oncology Shares Rising Today?
Taiho Pharmaceutical Co Ltd will co-develop and co-commercialize Cullinan Oncology Inc (NASDAQ: CGEM) lead program, CLN-081/TAS6417.
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
Cullinan Oncology Lead Cancer Program Shows Confirmed ORR Of 41% In Lung Cancer Setting
Cullinan Oncology Inc (NASDAQ: CGEM)
Cullinan Oncology Announces Clinical And Regulatory Update For CLN-081 In NSCLC EGFR Exon 20 Patients
Cullinan Oncology, Inc. (NASDAQ:CGEM) (Cullinan), a biopharmaceutical company focused on developing a diversified pipeline of targeted therapies for cancer patients, today announced clinical and regulatory
HC Wainwright & Co. Maintains Buy on Cullinan Oncology, Lowers Price Target to $53
HC Wainwright & Co. analyst Edward White maintains Cullinan Oncology (NASDAQ:CGEM) with a Buy and lowers the price target from $55 to $53.
